Delivery Order HHSN268201200003I-HHSN26800002
Award Date 4/16/12
Potential Completion Date 7/31/17
Potential Value $1.7M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Albuquerque, NM 87108, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency of the U.S. government, to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a non-profit contract research organization. The $706,056 cost-plus-fixed-fee task order is for LBERI to provide pharmacology-toxicology core laboratory services in support of the GTRP (Gene Therapy Resource Program) during fiscal year 2014, with a period of performance from February...
- This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a subsidiary of Lovelace Biomedical Research Institute. The $203,807.96 contract is a delivery order for Task Area A under the Pharmacology-Toxicology Core Lab task order 7 of the NHLBI's Gene Therapy Resource Program (GTRP). The work, which has no set-aside designation,...
- This is a delivery order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The $234,478 contract is for the Gene Therapy Resource Program (GTRP) Pharmacology and Toxicology Core Laboratory. It is a cost-plus-fixed-fee contract with a period of performance through June 30, 2024. Lovelace Biomedical Research Institute...
- This is a federal contract award to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization, by the National Heart Lung and Blood Institute (NHLBI). The $1,609,194.07 contract is a Delivery Order under the Gene Therapy Resource Program (GTRP) to provide pharmacology/toxicology core laboratory services for a scientific project. This work supports the National Institutes of Health's research efforts in gene therapy. The contract does not have a set-aside...
- This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to the Lovelace Biomedical Research Institute. The $1,143,792.16 cost-plus-fixed-fee contract is for the GENE THERAPY RESOURCE PROGRAM (GTRP) and calls for the awardee to provide a Pharmacology and Toxicology Core Laboratory. The contract does not have a set-aside designation. Lovelace Biomedical Research Institute is a not-for-profit...
- This is a $507,702.77 cost-plus-fixed-fee delivery order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI) to the Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The contract supports the NHLBI's Gene Therapy Resource Program (GTRP) by providing resources and services from three core laboratories focused on pharmacology and toxicology, preclinical vector development, and a clinical coordinating center. This contract...
- This federal contract award, valued at $1,013,722.26, was issued by the National Heart Lung and Blood Institute, a civilian agency, to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a not-for-profit contract research organization. The award is for the GTRP Pharmacology-Toxicology Core Lab, Task Order 6, Task Area B, with a period of performance through April 15, 2017. The contract is a cost-plus-fixed-fee delivery order, without a set-aside designation. LBERI, a...
- This is a delivery order under the Gene Therapy Resource Program (GTRP) contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH). The GTRP contract provides pharmacology and toxicology core laboratory services to support gene therapy research and development. The $10,766 delivery order was awarded to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. Lovelace will provide...
- This is a cost-plus-fixed-fee task order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart Lung and Blood Institute to Lovelace Biomedical Research Institute, a not-for-profit contract research organization. The $352,485.43 task order is for pharmacology/toxicology core laboratory services in support of the Gene Therapy Research Program (GTRP). It does not have a set-aside designation. Lovelace Biomedical has a history of serving as a...
- This federal contract award is for the Gene Therapy Resource Program (GTRP) Clinical Coordinating Center, which provides administrative support for translational gene therapy research. The contract was awarded to Social & Scientific Systems, Inc., a subsidiary of DLH Holdings Corp., a technology-enabled business process and program management solutions provider. The contract has a ceiling value of $2,888,003.09 and was awarded by the National Heart, Lung and Blood Institute (NHLBI), a part...